Prediction of morbidity and mortality from cardiac allograft vasculopathy.
For assessing clinical events associated with cardiac allograft vasculopathy, parameters relating to nonimmunological or immunological risk factors, epicardial coronary vessels, microvasculature, or left ventricular function may be utilized.